Updated 2026-08-31 · NCT07734311See eligibility →
Sponsor
Clinical trials sponsored by Hangzhou Sciwind Biosciences Co., Ltd.
Active studies whose public registry record names Hangzhou Sciwind Biosciences Co., Ltd. as lead sponsor.
5active studies
4recruiting now
1countries represented
1largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-08-28 · NCT07243171See eligibility →
Updated 2026-08-28 · NCT07387094See eligibility →
Updated 2026-08-28 · NCT07434050See eligibility →
Active, not recruitingPhase 2
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Updated 2026-04-13 · NCT07073417See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.